Apoptosis in neuronal development and transplantation: Role of caspases and trophic factors

Experimental Neurology

Volumn 156, Issue 1, 1999, Pages 1-15

  Boonman, Zita ^a   Isacson, Ole ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CASPASE; CASPASE INHIBITOR; CYCLIC AMP; CYSTEINE PROTEINASE; INTERLEUKIN 1BETA CONVERTING ENZYME; LAZAROID; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

APOPTOSIS; BRAIN GRAFT; BRAIN TRANSPLANTATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME INHIBITION; FETUS DEVELOPMENT; GENE DELETION; MESENCEPHALON; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033062724     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7056     Document Type: Review

References (146)

1. Abrous N., Guy J., Vigny A., Calas A., Le Moal M., Herman J. P. Development of intracerebral dopaminergic grafts: A combined immunohistochemical and autoradiographic study of its time course and environmental influences. J. Comp. Neurol. 273:1988;26-41.
2. Backman C., Rose G. M., Bartus R. T., Hoffer B. J., Mufson E. J., Granholm A. C. Carrier mediated delivery of NGF: Alterations in basal forebrain neurons in aged rats revealed using antibodies against low and high affinity NGF receptors. J. Comp. Neurol. 387:1997;1-11.
3. Backman C., Rose G. M., Hoffer B. J., Henry M. A., Bartus R. T., Friden P., Granholm A. C. Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J. Neurosci. 16:1996;5437-5442.
4. Barkats M., Nakao N., Grasbon-Frodl E. M., Bilang-Bleuel A., Revah F., Mallet J., Brundin P. Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase. Neuroscience. 78:1997;703-713.
5. Barker R. A., Dunnett S. B., Faissner A., Fawcett J. W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:1996;79-93.
6. Barker R. A., Fricker R. A., Abrous D. N., Fawcett J., Dunnett S. B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains,in vitroin vivo. Cell Transplant. 4:1995;173-200.
7. Bergeron L., Perez G. I., Macdonald G., Shi L., Sun Y., Jurisicova A., Varmuza S., Latham K. E., Flaws J. A., Salter J. C., Hara H., Moskowitz M. A., Li E., Greenberg A., Tilly J. L., Yuan J. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1998;1304-1314.
8. Bjorklund A. Intracerebral transplantation: Prospects for neuronal replacement in neurodegenerative diseases. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 71:1993;361-374.
9. Bjorklund A. Neurobiology. Better cells for brain repair. Nature. 362:1993;414-415.
10. Bjorklund A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
11. Bjorklund A., Stenevi U., Schmidt R. H., Dunnett S. B., Gage F. H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 522:1983;1-7.
12. Bjorklund A., Stenevi U., Schmidt R. H., Dunnett S. B., Gage F. H. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol. Scand. Suppl. 522:1983;9-18.
13. Brundin P., Barbin G., Isacson O., Mallat M., Chamak B., Prochiantz A., Gage F. H., Bjorklund A. Survival of intracerebrally grafted rat dopamine neurons previously culturedin vitro. Neurosci Lett. 61:1985;79-84.
14. Brundin P., Isacson O., Bjorklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:1985;251-259.
15. Brundin P., Isacson O., Gage F. H., Bjorklund A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Brain Res. 389:1986;77-84.
16. Burek M. J., Oppenheim R. W. Programmed cell death in the developing nervous system. Brain Pathol. 6:1996;427-446.
17. Caldero J., Prevette D., Mei X., Oakley R. A., Li L., Milligan C., Houenou L., Burek M., Oppenheim R. W. Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo. J. Neurosci. 18:1998;356-370.
18. Chinnaiyan A. M., O'Rourke K., Lane B. R., Dixit V. M. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science. 275:1997;1122-1126.
19. Chinnaiyan A. M., Orth K., O'Rourke K., Duan H., Poirier G. G., Dixit V. M. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271:1996;4573-4576.
20. Choi-Lundberg D. L., Lin Q., Chang Y. N., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
21. Clark R. S., Chen J., Watkins S. C., Kochanek P. M., Chen M., Stetler R. A., Loeffert J. E., Graham S. H. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J. Neurosci. 17:1997;9172-9182.
22. Clarkson E. D., Zawada W. M., Freed C. R. GDNF reduces apoptosis in dopaminergic neuronsin vitro. Neuroreport. 7:1995;145-149.
23. Clayton G. H., Mahalik T. J., Finger T. E. GAP-43 and 5B4-CAM immunoreactivity during the development of transplanted fetal mesencephalic neurons. Exp. Neurol. 114:1991;1-10.
24. Cohen G. M. Caspases: The executioners of apoptosis. Biochem. J. 326:1997;1-16.
25. Cohen G. M., Sun X. M., Snowden R. T., Dinsdale D., Skilleter D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:1992;331-334.
26. Collins R. J., Harmon B. V., Gobe G. C., Kerr J. F. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61:1992;451-453.
27. Costantini L. C., Snyder-Keller A. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants. Exp. Neurol. 145:1997;214-227.
28. Cotman C. W., Whittemore E. R., Watt J. A., Anderson A. J., Loo D. T. Possible role of apoptosis in Alzheimer's disease. Ann. N.Y. Acad. Sci. 747:1994;36-49.
29. Date I., Shingo T., Ohmoto T., Emerich D. F. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells. Exp. Neurol. 147:1997;10-17.
30. Date I., Yoshimoto Y., Gohda Y., Furuta T., Asari S., Ohmoto T. Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla in animal models of Parkinson's disease. Neurosurgery. 33:1993;685-690.
31. Deckwerth T. L., Johnson E. Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123:1993;1207-1222.
32. Deshmukh M., Johnson E. Jr. Programmed cell death in neurons: Focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51:1997;897-906.
33. Deshmukh M., Vasilakos J., Deckwerth T. L., Lampe P. A., Shivers B. D., Johnson E. Jr. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. 135:1996;1341-1354.
34. Dragunow M., MacGibbon G. A., Lawlor P., Butterworth N., Connor B., Henderson C., Walton M., Woodgate A., Hughes P., Faull R. L. Apoptosis, neurotrophic factors and neurodegeneration. Rev. Neurosci. 8:1997;223-265.
35. Du Y., Bales K. R., Dodel R. C., Hamilton-Byrd E., Horn J. W., Czilli D. L., Simmons L. K., Ni B., Paul S. M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11657-11662.
36. Du Y., Dodel R. C., Bales K. R., Jemmerson R., Hamilton-Byrd E., Paul S. M. Involvement of a caspase-3-like cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem. 69:1997;1382-1388.
37. Dunnett S. B., Bjorklund A. Basic neural transplantation techniques. I. Dissociated cell suspension grafts of embryonic ventral mesencephalon in the adult rat brain. Brain Res. Brain Res. Protoc. 1:1997;91-99.
38. Edwards S. N., Buckmaster A. E., Tolkovsky A. M. The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem. 57:1991;2140-2143.
39. Ellis H. M., Horvitz H. R. Genetic control of programmed cell death in the nematodeC. elegans. Cell. 44:1986;817-829.
40. Engele J., Franke B. Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways. Cell Tissue Res. 286:1996;235-240.
41. Friden P. M., Walus L. R., Watson P., Doctrow S. R., Kozarich J. W., Backman C., Bergman H., Hoffer B., Bloom F., Granholm A. C. Blood-brain barrier penetration andin vivo. Science. 259:1993;373-377.
42. Friedlander R. M., Gagliardini V., Hara H., Fink K. B., Li W., MacDonald G., Fishman M. C., Greenberg A. H., Moskowitz M. A., Yuan J. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185:1997;933-940.
43. Friel L. A., Blanchard B., Collier T. J., Elsworth J. D., Taylor J. R., Roth R. H., Redmond D. E. Jr., Sladek J. R. Jr. Effects of the calcium channel blocker nimopidine on the survival of intrastriatal ventral mesencephalic graftsin vitroin vivo. Am. Soc. Transplant. Abstr. 4:1998;48.
44. Frodl E. M., Nakao N., Brundin P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport. 5:1994;2393-2396.
45. Golstein P. Controlling cell death. Science. 275:1997;1081-1082.
46. Granholm A. C., Backman C., Bloom F., Ebendal T., Gerhardt G. A., Hoffer B., Mackerlova L., Olson L., Soderstrom S., Walus L. R. NGF and anti-transferrin receptor antibody conjugate: Short- and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J. Pharmacol. Exp. Ther. 268:1994;448-459.
47. Granholm A. C., Mott J. L., Bowenkamp K., Eken S., Henry S., Hoffer B. J., Lapchak P. A., Palmer M. R., van Horne C., Gerhardt G. A. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res. 116:1997;29-38.
48. Grasbon-Frodl E. M., Andersson A., Brundin P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67:1996;1653-1660.
49. Grasbon-Frodl E. M., Brundin P. Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E. Exp. Brain Res. 113:1997;138-143.
50. Grasbon-Frodl E. M., Nakao N., Brundin P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4°C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39:1996;341-347.
51. Hakem R., Hakem A., Duncan G. S., Henderson J. T., Woo M., Soengas M. S., Elia A., de la Pompa J. L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S. A., Lowe S. W., Penninger J. M., Mak T. W. Differential requirement for caspase 9 in apoptotic pathwaysin vivo. Cell. 94:1998;339-352.
52. Haque N. S., LeBlanc C. J., Isacson O. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant. 6:1997;239-248.
53. Hara H., Friedlander R. M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M. A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94:1997;2007-2012.
54. Hartikka J., Staufenbiel M., Lubbert H. Cyclic AMP, but not basic FGF, increases thein vitro. J. Neurosci. Res. 32:1992;190-201.
55. Haviv R., Lindenboim L., Li H., Yuan J., Stein R. Need for caspases in apoptosis of trophic factor-deprived PC12 cells. J. Neurosci. Res. 50:1997;69-80.
56. 2. Soc. Neurosci. Abstr. 24:1998;1056.
57. Hengartner M. O. Apoptosis. CED-4 is a stranger no more. Nature. 388:1997;714-715.
58. Hengartner M. O., Horvitz H. R. Programmed cell death inCaenorhabditis elegans. Curr. Opin. Genet. Dev. 4:1994;581-586.
59. Herrup K., Shojaeian-Zanjani H., Panzini L., Sunter K., Mariani J. The numerical matching of source and target populations in the CNS: The inferior olive to Purkinje cell projection. Brain Res. Dev. Brain Res. 96:1996;28-35.
60. Herzog K. H., Chong M. J., Kapsetaki M., Morgan J. I., McKinnon P. J. Requirement for atm in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1998;1089-1091.
61. Holm K., Isacson O. Factors intrinsic to the neuron can induce and maintain an ability for neurite outgrowth: A role for bcl-2. Trends Neurosci. 1999.
62. Holm K. H., Boonman Z., Tandon P., Costantini L. C., Deacon T. W., Chen D. F., Isacson O. Specific graft-host synaptic connections and long distance axonal growth in fetal neurotransplantation to adult CNS, 223.6. Soc. Neurosci. Abstr. 24:1998;557.
63. Houenou L. J., Oppenheim R. W., Li L., Lo A. C., Prevette D. Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res. 286:1996;219-223.
64. Hudson J. L., Bickford P., Johansson M., Hoffer B. J., Stromberg I. Target and neurotransmitter specificity of fetal central nervous system transplants: Importance for functional reinnervation. J. Neurosci. 14:1994;283-290.
65. Isacson O., Breakefield X. O. Benefits and risks of hosting animal cells in the human brain. Nature Med. 3:1997;964-969.
66. Isacson O., Deacon T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20:1997;477-482.
67. Isenmann S., Stoll G., Schroeter M., Krajewski S., Reed J. C., Bahr M. Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat. Brain Pathol. 8:1998;49-62.
68. Iwahashi H., Eguchi Y., Yasuhara N., Hanafusa T., Matsuzawa Y., Tsujimoto Y. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature. 390:1997;413-417.
69. Kaal E. C., Joosten E. A., Bar P. R. Prevention of apoptotic motoneuron deathin vitro. Neurochem. Int. 31:1997;193-201.
70. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
71. Kluck R. M., Martin S. J., Hoffman B. M., Zhou J. S., Green D. R., Newmeyer D. D. CytochromecXenopus. EMBO J. 16:1997;4639-4649.
72. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-562.
73. Krajewska M., Wang H. G., Krajewski S., Zapata J. M., Shabaik A., Gascoyne R., Reed J. C. Immunohistochemical analysis ofin vivo. Cancer Res. 57:1997;1605-1613.
74. Krobert K., Lopez-Colberg I., Cunningham L. A. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: Effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Exp. Neurol. 145:1997;511-523.
75. Kuida K., Haydar T. F., Kuan C. Y., Gu Y., Taya C., Karasuyama H., Su M. S., Rakic P., Flavell R. A. Reduced apoptosis and cytochromec. Cell. 94:1998;325-327.
76. Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S., Flavell R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
77. Kuida K., Zheng T. S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R. A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
78. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochromec. Cell. 91:1997;479-489.
79. Li Y., Chopp M., Powers C., Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 765:1997;301-312.
80. Lithgow T., van Driel R., Bertram J. F., Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ. 5:1994;411-417.
81. Lo A. C., Houenou L. J., Oppenheim R. W. Apoptosis in the nervous system: Morphological features, methods, pathology, and prevention. Arch. Histol. Cytol. 58:1995;139-149.
82. Lockshin R. A., Beaulaton J. Programmed cell death. Life Sci. 15:1974;1549-1565.
83. Loddick S. A., MacKenzie A., Rothwell N. J. An ICE inhibitor, zVAD-DCB, attenuates ischaemic brain damage in the rat. Neuroreport. 7:1996;1465-1468.
84. Lucca E., Angeretti N., Forloni G. Influence of cell culture conditions on the protective effect of antioxidants against beta-amyloid toxicity: Studies with lazaroids. Brain Res. 764:1997;293-298.
85. Macaya A., Munell F., Gubits R. M., Burke R. E. Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. USA. 91:1994;8117-8121.
86. Mahalik T. J., Hahn W. E., Clayton G. H., Owens G. P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:1994;27-36.
87. Margolin N., Raybuck S. A., Wilson K. P., Chen W., Fox T., Gu Y., Livingston D. J. Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases. J. Biol. Chem. 272:1997;7223-7228.
88. Marti M. J., James C. J., Oo T. F. W. J. K., Burke R. E. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17:1997;2030-2039.
89. Martinou J. C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
90. Mayer E., Fawcett J. W., Dunnett S. B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons - II. Effects on nigral transplantsin vivo. Neuroscience. 56:1993;389-398.
91. Mentz F., Mossalayi M. D., Ouaaz F., Debre P. Involvement of cAMP in CD3 T cell receptor complex- and CD2-mediated apoptosis of human thymocytes. Eur. J. Immunol. 25:1995;1798-1801.
92. Michaelidis T. M., Sendtner M., Cooper J. D., Airaksinen M. S., Holtmann B., Meyer M., Thoenen H. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron. 17:1996;75-89.
93. Michel P. P., Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J. Neurochem. 67:1996;1633-1642.
94. Mochizuki H., Goto K., Mori H., Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137:1996;120-123.
95. Mochizuki H., Mori H., Mizuno Y. Apoptosis in neurodegenerative disorders. J. Neural Transm. Suppl. 50:1997;125-140.
96. Nagy Z. S., Esiri M. M. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol. Aging. 18:1997;565-571.
97. Nakao N., Frodl E. M., Duan W. M., Widner H., Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12408-12412.
98. Nakao N., Frodl E. M., Widner H., Carlson E., Eggerding F. A., Epstein C. J., Brundin P. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:1995;226-231.
99. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K. J., Yuan J., Moskowitz M. A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
100. Nicholson D. W., Thornberry N. A. Caspases: Killer proteases. Trends Biochem. Sci. 22:1997;299-306.
101. Nikkah G., Cunningham M. G., Jodicke A., Knappe U., Bjorklund A. Improved graft survival and striatal reinnervation using a microtransplantation approach in the rat Parkinson model. Brain Res. 633:1994;133-143.
102. Nikkah G., Olsson M., Eberhard J., Bentlage C., Cunningham M. G., Bjorklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology. Neuroscience. 63:1994;57-72.
103. Oberhammer R. W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
104. Oo T. F., Henchcliffe C., Burke R. E. Apoptosis in substantia nigra following developmental hypoxic-ischemic injury. Neuroscience. 69:1995;893-901.
105. Oppenheim R. W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
106. Othberg A., Keep M., Brundin P., Lindvall O. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neuronsin vitro. Exp. Neurol. 147:1997;498-502.
107. Perlow M. J., Freed W. J., Hoffer B. J., Seiger A., Olson L., Wyatt R. J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 204:1979;643-647.
108. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
109. Portera-Cailliau C., Price D. L., Martin L. J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378:1997;88-104.
110. Rabizadeh S., LaCount D. J., Friesen P. D., Bredesen D. E. Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J. Neurochem. 61:1993;2318-2321.
111. Reed J. C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
112. Rosenblad C., Martinez-Serrano A., Bjorklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience. 75:1996;979-985.
113. Rosenblad C., Martinez-Serrano A., Bjorklund A. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience. 82:1998;129-137.
114. Rosse T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochromec. Nature. 391:1998;496-499.
115. Salvesen G. S., Dixit V. M. Caspases: Intracellular signaling by proteolysis. Cell. 91:1997;443-446.
116. Sautter J., Tseng J. L., Braguglia D., Aebischer P., Spenger C., Seiler R. W., Widmer H. R., Zurn A. D. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 149:1998;230-236.
117. Schielke G. P., Yang G. Y., Shivers B. D., Betz A. L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18:1998;180-185.
118. Schulz J. B., Beinroth S., Weller M., Wullner U., Klockgether T. Endonucleolytic DNA fragmentation is not required for apoptosis of cultured rat cerebellar granule neurons. Neurosci. Lett. 245:1998;9-12.
119. Shimizu S., Eguchi Y., Kamiike W., Itoh Y., Hasegawa J., Yamabe K., Otsuki Y., Matsuda H., Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 56:1996;2161-2166.
120. Sinclair S. R., Svendsen C. N., Torres E. M., Martin D., Fawcett J. W., Dunnett S. B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport. 7:1996;2547-2552.
121. Sloviter R. S., Dean E., Sollas A. L., Goodman J. H. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J. Comp. Neurol. 366:1996;516-533.
122. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E. S. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14486-14491.
123. Sulston J. E., Horvitz H. R. Post-embryonic cell lineages of the nematode,Caenorhabditis elegans. Dev. Biol. 56:1977;110-156.
124. Takayama H., Ray J., Raymon H. K., Baird A., Hogg J., Fisher L. J., Gage F. H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1:1995;53-58.
125. Tanaka H., Landmesser L. T. Cell death of lumbosacral motoneurons in chick, quail, and chick-quail chimera embryos: A test of the quantitative matching hypothesis of neuronal cell death. J. Neurosci. 6:1986;2889-2899.
126. Tews D. S., Goebel H. H., Meinck H. M. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol. Scand. 96:1997;380-386.
127. Tomei L. D., Shapiro J. P., Cope F. O. Apoptosis in C3H/10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA. 90:1993;853-857.
128. Troost D., Aten J., Morsink F., de Jong J. M. Apoptosis in ALS is not restricted to motoneurons: Bcl-2 expression is increased in post-central cortex, adjacent to the affected motor cortex. J. Neurol. Sci. 129:1995;79-80.
129. Troost D., Aten J., Morsink F., de Jong J. M. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol. Appl. Neurobiol. 21:1995;498-504.
130. Villa P., Kaufmann S. H., Earnshaw W. C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:1997;388-393.
131. Wang S., Miura M., Jung Y., Zhu H., Gagliardini V., Shi L., Greenberg A. H., Yuan J. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271:1996;20580-20587.
132. Wang S., Miura M., Jung Y. K., Zhu H., Li E., Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 92:1998;501-509.
133. Woo M., Hakem R., Soengas M. S., Duncan G. S., Shahinian A., Kagi D., Hakem A., McCurrach M., Khoo W., Kaufman S. A., Senaldi G., Howard T., Lowe S. W., Mak T. W. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:1998;806-819.
134. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
135. Wyllie A. H. Apoptosis: An overview. Br. Med. Bull. 53:1997;451-465.
136. Xue D., Shaham S., Horvitz H. R. TheCaenorhabditis elegans. Genes Dev. 10:1996;1073-1083.
137. Yakovlev A. G., Knoblach S. M., Fan L., Fox G. B., Goodnight R., Faden A. I. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17:1997;7415-7424.
138. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincon M., Zheng T. S., Davis R. J., Rakic P., Flavell R. A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:1997;865-870.
139. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2: Release of cytochromec. Science. 275:1997;1129-1132.
140. Yang J. C., Cortopassi G. A. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochromec. Free Radical Biol. Med. 24:1998;624-631.
141. Yuan J., Shaham S., Ledoux S., Ellis H. M., Horvitz H. R. TheC. elegans. Cell. 75:1993;641-652.
142. Yurek D. M., Collier T. J., Sladek J. R. Jr. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:1990;191-199.
143. Yurek D. M., Lu W., Hipkens S., Wiegand S. J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:1996;105-118.
144. Zawada W. M., Kirschman D. L., Cohen J. J., Heidenreich K. A., Freed C. R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 140:1996;60-67.
145. Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P., Freed C. R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.
146. Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous toC. elegansc. Cell. 90:1997;405-413.